Form 4: Upstream Bio Director Acquires Stock Options

Marcela K. Ruddy, a director at Upstream Bio, Inc., acquired stock options for 17,096 shares of common stock on October 10, 2024.

Summary

• On October 10, 2024, Marcela K. Ruddy, a director of Upstream Bio, Inc., acquired stock options to purchase 17,096 shares of the company's common stock.
• The exercise price of these options is $17.
• The options vest on the earlier of October 10, 2025, or the date of the next Annual Meeting of Stockholders, contingent upon continued service.
• The options expire on October 9, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director, which is neither overtly positive nor negative.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director could signal confidence in the company's future, potentially impacting shareholder sentiment positively.

Key Dates